Trials of a potentially curative remedy for type 1 diabetes (T1D) will continue, after the US Food and Drug Administration lifted a clinical hold on the candida 6 July 2022
French pharma major Sanofi has launched a new nonprofit project designed to help at-risk populations in the world’s least developed countries. 4 July 2022
One UK-based company is looking to transform the way metabolic disorders are treated, leveraging many of the same AI-based techniques used to great effect elsew 4 July 2022
The race to meet sudden, stratospheric demand for new anti-obesity meds is hotting up, but Novo Nordisk CEO Lars Fruergaard Jørgensen takes a collegiate approac 26 May 2022
Indiana, USA-based drugmaker Eli Lilly is making a major investment in its home state, with a $2.1 billion project to expand its manufacturing footprint. 26 May 2022
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.